Published • loading... • Updated
Texas Law Allowing Ivermectin to Be Sold Over the Counter Goes Into Effect
House Bill 25 reclassifies ivermectin as an over-the-counter drug, increasing access and potentially benefiting local pharmacies, especially in East Texas, supporters say.
- On Dec. 4, House Bill 25 took effect in Texas, reclassifying ivermectin as over-the-counter and allowing sales without prescriptions at pharmacies and drug stores.
- Supporters including Gov. Greg Abbott framed the move as restoring medical freedom; State Representative Cody Harris said it returns power to Texans and expands ivermectin access.
- Local pharmacists say the change will boost demand in East Texas, especially among alternative-medicine patients, while Dr. Alex Perez warned improper use may cause encephalopathy, dizziness, or liver issues.
- Allowing pharmacists to dispense the drug without a prescription will accelerate access in rural communities and supporters say the reduced regulation could help small, locally owned pharmacies stay open.
- Federal guidance remains that ivermectin is not FDA‑approved for COVID‑19, while providers may prescribe off‑label; other Texas laws taking effect Dec. 3 include House Bill 4 on congressional maps.
Insights by Ground AI
9 Articles
9 Articles
+4 Reposted by 4 other sources
Texas Law Allowing Ivermectin to Be Sold Over the Counter Goes Into Effect
A Texas law allowing ivermectin to be sold over the counter went into effect Dec. 4, but rollout appears slow as pharmacies wrestle with how to proceed. House Bill 25, signed into law by Gov. Greg Abbott in August, allows pharmacies to sell the antiviral drug without a prescription. Ivermectin gained popularity for off-label use during the COVID-19 pandemic, which influenced support and criticism of the measure. The drug was discovered in the 19…
·New York, United States
Read Full ArticleCoverage Details
Total News Sources9
Leaning Left0Leaning Right4Center4Last UpdatedBias Distribution50% Center, 50% Right
Bias Distribution
- 50% of the sources are Center, 50% of the sources lean Right
50% Right
C 50%
R 50%
Factuality
To view factuality data please Upgrade to Premium








